Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review
IVIG and MMF showed effectiveness in corticosteroid-refractory CIP, and further investigation is warranted to establish standardized guideline and to optimize therapeutic drug monitoring for immunosuppressive agents.
Authors
- Wencheng Yin (ORCID: https://orcid.org/0009-0003-1869-5891)
- X H Liu
- Yan’e Liu
- Liang Li (ORCID: https://orcid.org/0000-0002-2882-2116)
- Wei Liu (ORCID: https://orcid.org/0000-0002-1773-5156)
- Jingjing Yu (ORCID: https://orcid.org/0000-0002-3850-9238)
- Qian Li (ORCID: https://orcid.org/0000-0002-6084-1712)
- Xian‐Li Ma (ORCID: https://orcid.org/0000-0003-4146-8366)
- Baoshan Cao (ORCID: https://orcid.org/0000-0001-7939-4820)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Peking University International Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Clinical Pharmacology Advances and Applications
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/cpaa.s534323
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00